Med LifeBSE:M +4.04%92 Days Payable is 209.36 as of Mar. 2026, which is 35% below its 10-year median of 323.79. GuruFocus rates BSE:M with a GF Score™ of 92/100 and a GF Value™ of lei7.84 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Med Life ranks better than 89.62% on this metric.
Med Life's average Accounts Payable for the
three
months ended in Mar. 2026 was lei394 Mil. Med Life's Cost of Goods Sold for the
three
months ended in Mar. 2026 was lei172 Mil.
Hence, Med Life's Days Payable for the
three
months ended in Mar. 2026 was 209.36.
The historical rank and industry rank for Med Life's Days Payable or its related term are showing as below:
BSE:M'
s Days Payable Range Over the Past 10 Years
Min: 256.42 Med: 323.79 Max: 376.78
Current: 290.88
During the past 11 years, Med Life's highest Days Payable was 376.78. The lowest was 256.42. And the median was 323.79.
BSE:M's Days Payable is ranked better than 89.62% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58.16
vs BSE:M: 290.88
Med Life's Days Payable
declined
from Dec. 2024 (259.82) to Mar. 2026 (209.36).
It may suggest that Med Lifeaccelerated paying its suppliers.
Med Life Days Payable Related Terms
Med Life Days Payable Historical Data
* Premium members only.
The historical data trend for Med Life's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Med Life's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med Life Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Med Life's Days Payable distribution charts can be found below:
* The bar in red indicates where Med Life's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Med Life's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med Life (BSE:M) has a Days Payable of 209.36 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Med Life and its competitors. This is 35% below median its historical median of 323.79. Over the past decade, Med Life's Days Payable has ranged from 256.42 to 376.78. According to the industry distribution chart, Med Life ranks #63 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 10.4%.
Is Med Life's Days Payable too high?
Med Life's current Days Payable of 209.36 is 35% below median its 10-year median of 323.79. Over the past 10 years, this metric has ranged from a low of 256.42 to a high of 376.78. The Healthcare Providers & Services industry median Days Payable is 58.16. Med Life's value of 209.36 is 260% above this industry median. Based on the distribution chart, Med Life ranks #63 out of 607 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Med Life has a GF Score™ of 92/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Med Life ranks #63 out of 607 companies for Days Payable. This places Med Life in the top 10% of its industry — outperforming the majority of peers. The industry median Days Payable is 58.16. Med Life's value of 209.36 is 260% above this benchmark. Historically, Med Life's own Days Payable has ranged from 256.42 to 376.78 over the past decade. While the company's 10-year median is 323.79 vs. the industry median of 58.16, Med Life has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.16, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med Life's current Days Payable of 209.36 is 260% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Med Life and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Life's current Days Payable is 209.36, which is 35% below median its own 10-year median of 323.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (BSE:M) is currently considered Significantly Overvalued. The stock's GF Value™ is lei7.84, compared to a current price of lei11.86 — trading 51.3% above its estimated fair value. The current Days Payable is 209.36, which is 35% below median its 10-year median of 323.79 and 260% above the Healthcare Providers & Services industry median of 58.16. Med Life's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Med Life (BSE:M), the current Days Payable is 209.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Med Life (BSE:M) Overvalued in 2026?
Based on GuruFocus' analysis, Med Life stock appears to be overvalued.
The current stock price of lei11.86 is trading 51.3% above its estimated GF Value™ of lei7.84.
GuruFocus considers Med Life to be Significantly Overvalued.
Key valuation signals for BSE:M:
Days Payable: 209.36 (35% below median its 10-year median of 323.79)
GF Value™: lei7.84 vs. price of lei11.86 (51.3% above fair value)
Industry Position: 260% above the Healthcare Providers & Services median (#63 of 607)
No single metric tells the full story. See the BSE:M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
92GF Score
Get the complete analysis for BSE:M
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSE:M has been successfully added to your 
